Research Advances on Gut–Brain Axis in Parkinson’s Disease Pathogenesis and Prodromal Prediction

Parkinson’s Disease (PD) is a common chronic progressive neurodegenerative disorder. Traditionally, it has been considered to be a disorder confined to dopaminergic neuronal injury in the substantia nigra of the central nervous system. However, increasing evidence from epidemiology, clinical imaging, and molecular biology suggests that the pathological process of PD may begin in the gut, with the gut–brain axis participating in disease initiation and progression. This review systematically summarizes the structural and physiological regulatory mechanisms of the gut–brain axis, focusing in particular on the aggregation of α-synuclein in the gut and its prion-like propagation, features of gut microbiota dysbiosis, leaky gut and systemic inflammatory cascades, and vagus nerve–related transmission mechanisms. Centering on prodromal PD, we discuss in depth early biomarkers based on this framework and propose a multi-dimensional combinatorial strategy integrating gut microbiota, barrier-related molecules and prodromal clinical phenotypes, to provide new perspectives for the prodromal prediction of PD.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-12
DOI
https://doi.org/10.3390/ijms272210126
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Research Advances on Gut–Brain Axis in Parkinson’s Disease Pathogenesis and Prodromal Prediction

Yi Li, Wenyi Du, Jian Wu, Wanqing Zhu et al.
International Journal of Molecular Sciences
Parkinson's Disease Mechanisms and Treatments
article

Research Advances on Gut–Brain Axis in Parkinson’s Disease Pathogenesis and Prodromal Prediction

Yi Li, Wenyi Du, Jian Wu, Wanqing Zhu, Leying Huang, Jiaqi Zhai
article en

Abstract

Parkinson’s Disease (PD) is a common chronic progressive neurodegenerative disorder. Traditionally, it has been considered to be a disorder confined to dopaminergic neuronal injury in the substantia nigra of the central nervous system. However, increasing evidence from epidemiology, clinical imaging, and molecular biology suggests that the pathological process of PD may begin in the gut, with the gut–brain axis participating in disease initiation and progression. This review systematically summarizes the structural and physiological regulatory mechanisms of the gut–brain axis, focusing in particular on the aggregation of α-synuclein in the gut and its prion-like propagation, features of gut microbiota dysbiosis, leaky gut and systemic inflammatory cascades, and vagus nerve–related transmission mechanisms. Centering on prodromal PD, we discuss in depth early biomarkers based on this framework and propose a multi-dimensional combinatorial strategy integrating gut microbiota, barrier-related molecules and prodromal clinical phenotypes, to provide new perspectives for the prodromal prediction of PD.

International Journal of Molecular SciencesVol. 27(22)
Nantong University (CN)
Good health and well-being
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon